Protein stability and degradation in health and disease
Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Standard
Protein stability and degradation in health and disease. / Clausen, Lene; Abildgaard, Amanda Bering; Gersing, Sarah K.; Stein, Amelie; Lindorff-Larsen, Kresten; Hartmann-Petersen, Rasmus.
Molecular Chaperones in Human Disorders. red. / Rossen Donev. Academic Press, 2019. s. 61-83 (Advances in Protein Chemistry and Structural Biology, Bind 114).Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - Protein stability and degradation in health and disease
AU - Clausen, Lene
AU - Abildgaard, Amanda Bering
AU - Gersing, Sarah K.
AU - Stein, Amelie
AU - Lindorff-Larsen, Kresten
AU - Hartmann-Petersen, Rasmus
PY - 2019
Y1 - 2019
N2 - The cellular proteome performs highly varied functions to sustain life. Since most of these functions require proteins to fold properly, they can be impaired by mutations that affect protein structure, leading to diseases such as Alzheimer's disease, cystic fibrosis, and Lynch syndrome. The cell has evolved an intricate protein quality control (PQC) system that includes degradation pathways and a multitude of molecular chaperones and co-chaperones, all working together to catalyze the refolding or removal of aberrant proteins. Thus, the PQC system limits the harmful consequences of dysfunctional proteins, including those arising from disease-causing mutations. This complex system is still not fully understood. In particular the structural and sequence motifs that, when exposed, trigger degradation of misfolded proteins are currently under investigation. Moreover, several attempts are being made to activate or inhibit parts of the PQC system as a treatment for diseases. Here, we briefly review the present knowledge on the PQC system and list current strategies that are employed to exploit the system in disease treatment.
AB - The cellular proteome performs highly varied functions to sustain life. Since most of these functions require proteins to fold properly, they can be impaired by mutations that affect protein structure, leading to diseases such as Alzheimer's disease, cystic fibrosis, and Lynch syndrome. The cell has evolved an intricate protein quality control (PQC) system that includes degradation pathways and a multitude of molecular chaperones and co-chaperones, all working together to catalyze the refolding or removal of aberrant proteins. Thus, the PQC system limits the harmful consequences of dysfunctional proteins, including those arising from disease-causing mutations. This complex system is still not fully understood. In particular the structural and sequence motifs that, when exposed, trigger degradation of misfolded proteins are currently under investigation. Moreover, several attempts are being made to activate or inhibit parts of the PQC system as a treatment for diseases. Here, we briefly review the present knowledge on the PQC system and list current strategies that are employed to exploit the system in disease treatment.
KW - Chaperone
KW - Misfolding
KW - Proteasome
KW - Protein folding
KW - Protein quality control
KW - Ubiquitin
U2 - 10.1016/bs.apcsb.2018.09.002
DO - 10.1016/bs.apcsb.2018.09.002
M3 - Book chapter
C2 - 30635086
AN - SCOPUS:85057239152
SN - 978-0-12-815557-8
T3 - Advances in Protein Chemistry and Structural Biology
SP - 61
EP - 83
BT - Molecular Chaperones in Human Disorders
A2 - Donev, Rossen
PB - Academic Press
ER -
ID: 212497738